Prescription Required
This drug is considered to be safe for children in treating nausea and vomiting.
It is mainly provided to patients suffering from nausea and vomiting related to radiotherapy, surgery, stomach infections, and chemotherapy.
It should be taken cautiously by the patients suffering from severe liver disease.
The drug is safe for kidney patients; no dose adjustment is required.
It does not cause any harmful effects while drinking alcohol with this medicine.
It does not affect driving ability.
It is generally considered to be safe while pregnancy.
It is generally considered to be safe during breastfeeding.
Ondansetron is an antiemetic that prevents nausea and vomiting, often used during chemotherapy or after surgery.
Nausea and vomiting are symptoms that can be caused by a variety of conditions, including gastrointestinal disorders, infections, and medication side effects.
No, Vomihalt is an antiemetic and not a steroid. Vomihalt is a selective 5-HT3 receptor antagonist. It is prescribed for the prevention and treatment of nausea and vomiting which is commonly observed after surgery or due to cancer chemotherapy.
The most common side effects of Vomihalt are constipation, diarrhea, fatigue and headache. However, these are usually not bothersome and resolve on their own after some time. Consult your doctor if these persist or worry you.
No, Vomihalt does not work for seasickness. This is because Vomihalt has very little effect on the nausea associated with motion sickness.
Vomihalt should be taken with a full glass of water, with or without food. It should be used exactly as per the dose and duration advised by the doctor. Usually, the first dose of Vomihalt is taken before the start of your surgery, chemotherapy or radiation treatment.
Vomihalt starts working within half an hour to 2 hours. It dissolves rapidly into the bloodstream and starts showing its effect.
M.Pharma
Content Updated on
Tuesday, 9 July, 2024Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA